Skip navigation

 Login or Register | Member Centre

Posted AT 9:17 AM EST on 08/08/08

Labopharm loss narrows

The Canadian Press

LAVAL, Que. — Drug developer Labopharm Inc. reported Friday a second-quarter net loss of $10.1-million, narrowed from a year-ago $11-million The loss amounted to 18 cents per share, compared with 19 cents per share in the second quarter of fiscal 2007. Total revenue declined to $4.9-million from $5.9-million in the prior-year quarter. Revenue from product sales was $3.9-million, versus $4.

The full text of this article has 192 words.

To continue reading this article, you will need to purchase this article.

Already have a member account? Login now

Pay-Per-View Offers To read the complete article, select one of the following options

Purchasing from globeandmail.com is quick and secure.

Single Article: $4.95

4-pack: $17.95

MOST POPULAR 

Adhocracy 

Jennifer Wells
And now, naked sheep
Plus: Naked-naked, but in a natural way

Consumer Electronics 

A shop attendant works on a laptop at a computer store in Taipei December 30, 2008.
Future dims for desktop
as laptop sales surge
Consumers won over by competitive price, performance and portability; manufacturers race to expand choices Comment4

The Law Page 

Michael Fortier
Back in the M&A world
After stints in public service, Michael Fortier rejoins Ogilvy

Globe Investor Magazine 

Ten things to know about TFSAs
Ten things to know about TFSAs
The nuts and bolts of these new tax-sheltered accounts -- and who benefits most from them
Related: Tax-Free Savings Account ideal as emergency backup fund

Restaurant Diary 

Jenny Wagler
Dine and dash
"Party math" makes large groups risky for servers

Magazine Exclusive 

Peter Pocklington
Peter Puck's last stand
In 2002, the former Oilers owner moved to California, leaving bailouts and ill will in his wake. For unwitting new partners in the U.S., a golden entrepreneur seemed to have swept into town 7:04 AM Lock

Insights 

Back to top